Market Tracker

06/29 4:04pm ET

EPIRUS Biopharmaceuticals Inc (NASDAQ:EPRS)

0.49
Delayed Data
As of 3:49pm ET
 0.00 / 0.00%
Today’s Change
0.39
Today|||52-Week Range
8.75
-84.14%
Year-to-Date
No recent news for EPIRUS Biopharmaceuticals Inc.

Today’s Trading

Previous close0.49
Today’s open0.50
Day’s range0.45 - 0.50
Volume590,614
Average volume (3 months)497,029
Market cap$12.8M
Dividend yield--
Data as of 3:49pm ET, 06/29/2016

Growth & Valuation

Earnings growth (last year)+66.37%
Earnings growth (this year)+58.26%
Earnings growth (next 5 years)--
Revenue growth (last year)+17,425.00%
P/E ratioNM
Price/Sales100.27
Price/Book0.33

Competitors

 Today’s
change
Today’s
% change
HTBXHeat Biologics Inc+0.01+1.43%
RTTRRitter Pharmaceutica...-0.15-9.37%
GNVCGenVec Inc-0.00-0.38%
CBIOCatalyst Biosciences...+0.09+7.25%
Data as of 3:49pm ET, 06/29/2016

Financials

Next reporting dateAugust 5, 2016
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$701.0K
Annual profit (last year)-$52.2M
Net profit margin-7,444.79%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Independent Director
Scott M. Rocklage
President &
Chief Operating Officer
Michael Wyand
Corporate headquarters
Boston, Massachusetts

Forecasts